Do not use this guideline Individualize patient evaluation for excluded groups Patients with symptoms concerning for complications: Periorbital cellulitis.

Slides:



Advertisements
Similar presentations
Chest Infections Lawrence Pike.
Advertisements

Periorbital and Orbital Cellulitis
Periorbital and Orbital Infections
Sinusitis By Emilie Watson.
Upper Respiratory Tract Infections Dr. Meenakshi Aggarwal MD Emory Family Medicine.
Nursing Care of Clients with Upper Respiratory Disorders.
Community Acquired Pneumonia Guidelines 2011 Top 11 Recommendations Michael H. Kim.
Michael De Vito M.D. Capital Region Otolaryngology Group
Grand Rounds Conference Eric Downing MD University of Louisville Department of Ophthalmology and Visual Sciences.
Sniffing out the problem Jonathan Hern. Commissioning Guide for Chronic Rhinosinusitis ENTUK and RCS Based on European position paper on sinusitis Guidance.
Objectives Describe clinical criteria for Diagnosis of Acute Bacterial Sinusitis (ABS) Understand the pathophysiology and complications of ABS Learn.
Prepared for your next patient.
Pneumonia & Respiratory Tract Infection: Antibiotic risk for Clostridium difficile Kieran Hand*, Adil Ahmed †, Adriana Basarab ¶, Whitney Chow †, Nick.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Community Acquired Pneumonia in Children June 2014 Pediatric Continuity Clinic Curriculum Created by: Cecile Besingi.
AAP Clinical Practice Guideline: Management of Sinusitis Pediatrics 108:798, 2001 (Sep)
Sinusitis Laura Saldivar, M.D. Duke Children’s Primary Care HOCC Preclinic Conference February 2008.
Upper respiratory tract infections
Treatment of urinary tract infections
SORE THROAT & OTITIS MEDIA
Prof.Hanan Habib. To eradicate the offending organisms from the urinary bladder and tissues. The main treatment of UTI is by antibiotics.
1 One Year Post-Exclusivity Adverse Event Review: Ertapenem Pediatric Advisory Committee Meeting November 16, 2006 Alan M. Shapiro, MD, PhD, FAAP Medical.
Unit 5: IPT Isoniazid TB Preventive Therapy
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Antibiotic Use in URTI Gary Kroukamp ENT Specialist Kingsbury Hospital.
10/11/ Dr Mostafavi N Pediatric infectious disease departement Isfahan university of medical sciences 10/11/13922.
RESPIRATORY TRACT INFECTIONS: ANTIBIOTIC PRESCRIBING
Individualize patient evaluation for excluded groups Children < 2 months of age, consider sepsis evaluation Immunodeficiences Sensory deficits Age consideration.
The Role of Imaging in Sinusitis Dr Mohamed El Safwany, MD.
H1N1 General Information Update Karen Dahl, MD Pediatric Infectious Diseases.
32 yo woman with sinusitis Started with runny nose, cough, and sore throat 10 days ago Developed nasal congestion and drainage 1 day later On day 6 seen.
Orbit 2 Orbital infections Dr. Mohammad Shehadeh.
Bronchitis in children. Acute upper respiratory tract infections Prof. Pavlyshyn H.A., MD, PhD.
PHARMACOLOGY CONFERENCE
بسم الله الحمن الرحيم (قل ان صلاتي و نسكي و محياي ومماتي لله رب العالمين لا شريك له وبدلك امرت وأنا اول المسلمين) طه
Treatment of urinary tract infections Prof. Hanan Habib.
Morning Report July 3, 2012 Good Morning!. Symptoms Acute /subacuteChronic LocalizedDiffuse SingleMultiple StaticProgressive ConstantIntermittent Single.
PEDIATRIC MEDICATION CALCULATIONS
1 Exploring Alternative Antibiotic Treatment Regimens: Methodology and Implications Dr. Tabish Hazir MASCOT Study Group 2 nd ICIUM Conference 2004.
Sinusitis Camilla Curren, M.D. The Ohio State University College of Medicine Division of General Internal Medicine
Rhinitis, Sinusitis and beyond: what the primary care provider should know Marika Russell, MD, FACS Assistant Professor of Clinical Otolaryngology San.
SINUSITIS & ITS COMPLICATIONS
1 Observations from Past Approvals for Acute Bacterial Sinusitis Janice Pohlman, M.D. AIDAC Meeting, October 29, 2003.
Treatment of urinary tract infections
TREATMENT OF SEVERE PNEUMONIA WITH ORAL ANTIBIOTICS Lozano JM, on behalf of the APPIS Trial Group. Department of Pediatrics and Clinical Epidemiology Unit,
AOM. Otitis Media  Otitis Media with effusion (OME)  Acute Otitis Media (AOM)  Recurrent AOM  Chronic Otitis Media/Chronic Otitis Media with effusion.
A Clinician’s Approach to Treatment.  To understand the definition of cellulitis  To know what treatment is appropriate  To know when hospitalization.
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
1 Recent Advances in Provision of Primary Care in the Public Sector: Is 3 Days of Oral Antibiotic Therapy Enough for Treatment of Ambulatory Pneumonia?
Sinusitis Dr.Emamzadegan Ped.Cardiologist. Sinusitis Sinusitis is a common illness of childhood and adolescence.
Using Antibiotics Wisely Team Lead Call #6 Diane Liu, MD Assistant Professor, Pediatrics Co-Director, UPIQ.
Upper Respiratory Tract Infections (URIs) Dr Simin Dashti-Khavidaki, Department of Pharmacotherapy, Tehran University of Medical Sciences.
Management: Patient Diagnostics: CBC and PC to check for infection, Chest X ray IVF: D5IMB to run at 35 ml/hr Medications: 1. NSS nebulization 2 ml q6h.
PARANASAL MUCOCELE IN CYSTIC FIBROSIS CHILDREN °Di Cicco M. MD *Costantini D.MD. *Colombo C.MD °Otorhinolaryngology Dept., *Pediatrics Dept. CF Centre,
Amoxicillin for Acute Rhinosinusitis A Randomized Controlled Trial Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. JAMA 2012;307(7): Prof.
Depart. Of Pulmonology & Critical Care Medicine R4 백승숙 Barbara J. Turner, Sankey Williams, Darren Taichman.
Department of Otorhinolaryngology
IDSA CLINICAL PRACTICE GUIDELINE FOR ACUTE BACTERIAL RHINOSINUSITIS IN CHILDREN AND ADULTS CLINICAL INFECTIOUS DISEASES ADVANCE ACCESS PUBLISHED MARCH.
Copyright © 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. Musculoskeletal Disorders.
Choosing Wisely Urgent and Emergent Care
Jessica Case study.
Evaluation and Treatment of Children with Bronchiolitis in the Emergency Department Suspected bronchiolitis: Otherwise healthy child < 24 months of age.
Management of Urinary Tract Infections Renal Block
Management of Urinary Tract Infections Renal Block
Evaluation and Treatment of Children with Bronchiolitis in the Emergency Department Suspected bronchiolitis: Otherwise healthy child < 24 months of age.
Otitis Media.
Lower respiratory infections
Introduction to Antimicrobial Stewardship: Bugs and Drugs
Dr Immaculate Kariuki Consultant Paediatrician Nairobi, Kenya
Presentation transcript:

Do not use this guideline Individualize patient evaluation for excluded groups Patients with symptoms concerning for complications: Periorbital cellulitis Subperiosteal abscess Intracranial abscess First line antibiotic therapy is Amoxicillin mg/kg/day PO divided two times a day for days. Max daily dose is 750 mg to 1.5 grams/day. Up to 4 weeks of purulent nasal drainage accompanied by nasal obstruction, facial pain-pressure-fullness, or both Radiologic studies (plain films, CT, MRI, or ultrasound) to confirm routine ABS are not recommended or indicated Under 1 year of age Chronic sinusitis Ciliary dyskinesia Immune deficiencies Cystic fibrosis and other chronic lung conditions Identified periorbital, orbital, or intracranial abscess Observe without antibiotics. Treat as Upper Respiratory Tract Infection (URI) with symptomatic treatment: Acetaminophen or ibuprofen Nasal steroids if allergic component Over the counter (OTC) nasal saline spray Evaluate patient for either symptom/sign: Persistent symptoms lasting > days consisting of nasal discharge or persistent cough without evidence of improvement Option for antibiotic therapy OR additional observation for 3 days Reassess if worsening or failure to improve within 72 hours This guideline is not intended to replace a provider’s judgment, but rather to support the decision-making process, which must be individualized for each patient’s circumstances. Pediatric Patient Presents with Signs/Symptoms of Acute Rhinorrhea Upper Respiratory Symptoms Persistent Exclusion Criteria Antibiotic Treatment IS Indicated for Pediatric Patients Diagnosed With ABS High Risk Patient Exclusion Upper Respiratory Symptoms Less Severe Assess Pediatric Patient for Acute Bacterial Sinusitis (ABS) Third line antibiotics include the following for day therapy: Cefdinir (Omnicef) 14 mg/kg/day PO taken once daily or the dose can be divided two times a day. Max daily dose is 600 mg/day. OR Cefprozil (Cefzil) 30 mg/kg/day divided two times a day. Max dose is daily adult dose gram/day. OR Clindamycin (Cleocin) 40 mg/kg/day divided three times a day (penicillin allergy). Max dose is daily adult dose 1.8 grams/day. Second line therapy is Amoxillicin-clavulanate (Augmentin) and dosing is dependent upon concentration: At 400 mg/5 ml, give mg/kg/day divided two times a day for days. Max daily dose for children and adolescent > 40 kg and adult dose: 500 mg every 8 hours using the 500 mg tablet ONLY - OR 875 mg every 12 hours using the 875 mg tablet. At 600 mg/5 ml, give mg/kg/day divided two times a day for days. Per the manufacturer, the 600 mg/5 mL formulation should only be used for patients weighing <40 kg (max 3.6 grams/day). Children and adolescents ≥ 40 kg and adult dose: 2000 mg (two 1000 mg extended release tablets) every 12 hours. Concerning Complications Do not use this guideline if complications for ABS are suspected Consider consult with ENT or Ophthalmology and/or Imaging High Risk Patient Exclusion Evaluate patient for either symptom/sign: Worsening symptoms after 6 days of symptoms consisting of new-onset fever ≥ ⁰ F/38 ⁰ C or increased nasal discharge or cough after initial improvement Ill appearing child with symptoms lasting for > 3 consecutive days consisting of documented fever of ≥ 102 ⁰ F/38.9 ⁰ C AND purulent nasal discharge Upper Respiratory Symptoms More Severe or Worsening Ceftriaxone (Rocephin) 50 mg/kg/single IM dose to initiate therapy in patients unable to initially take PO therapy. Max dose is daily adult dose 1 gram. Antibiotic Treatment IS NOT Indicated Pediatric Acute Bacterial Sinusitis (ABS) Guideline Page DOHFinal

This guideline is not intended to replace a provider’s judgment, but rather to support the decision-making process, which must be individualized for each patient’s circumstances. Only 6.5% of URIs go on to develop ABS Radiologic studies (plain films, CT, MRI, or ultrasound) to confirm ABS are not recommended or indicated High risk groups are excluded from the algorithm (see exclusion criteria) Be alert to complications of ABS, such as periobital cellulitis and subperiosteal abscess, and the clinical signs and symptoms most likely to occur with these diagnoses (periorbital swelling, chemosis, visual impairment, ophthalmoplegia, facial pain, etc) If diagnosis is unsure and the patient looks well, follow up with the patient’s PCP or ENT is appropriate rather than prescribing an antibiotic without a definite diagnosis Nasal purulence alone is not a reliable indicator for the diagnosis of ABS verses URI Patients with persistent symptoms have the option for antibiotic therapy or additional observation for 3 days. This is an opportunity for shared decision-making with the child’s family. If observation is offered, a mechanism must be in place to ensure follow-up and begin antibiotics if the child worsens at any time or fails to improve within 3 days of observation. Azithromycin is not recommended; Clindamycin or Cefdinir is recommended if patient has a penicillin allergy High dose recommended for patients with any of the following: Moderate to severe infection, age < 2 years, childcare attendance, or recent antibiotic treatment (per AAP, Wald, 2013) OR Areas with high endemic rates of penicillin-nonsusceptible S. pneumoniae, patients with severe infections, daycare attendance, age < 2 years, recent hospitalization, antibiotic use within the past month, or patients who are immunocompromised (per IDSA, Chow, 2012) 1.Shapiro, D., Gonzales, R., Cabana, M., Hersh, A. (2011, January). National trends in visit rates and antibiotic prescribing for children with acute sinusitis. Pediatrics, 127(1). 2.Wald, E., Applegate, K., Bordley, C., Darrow, D., et al (2013, July 1). Clinical practice guidelines for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics, 132(1):e262-e Wald, E., Nash, D., Eickhoff, J. (2009, July). Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics, 124(1). References Clinical Pearls Pediatric Acute Bacterial Sinusitis (ABS) Guideline Page DOHFinal